# A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA

> **NCT06535685** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** Romiplostim

## Key facts

- **NCT ID:** NCT06535685
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-02
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06535685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06535685, "A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06535685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*